MARC details
000 -LEADER |
fixed length control field |
02541cam a2200385Ii 4500 |
001 - CONTROL NUMBER |
control field |
ocn970680865 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20180722225353.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
170128t20172009nyuaf b 001 0 eng d |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
BTCTA |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
BTCTA |
Modifying agency |
BDX |
-- |
YDX |
-- |
JRZ |
-- |
UOK |
-- |
BIB |
-- |
OCLCF |
-- |
NFG |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780452295728 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0452295726 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)970680865 |
041 1# - LANGUAGE CODE |
Language code of text/sound track or separate title |
eng |
Language code of original and/or intermediate translations of text |
fre |
092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC) |
Classification number |
616.994 |
Item number |
S491 |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
NFGA |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Servan-Schreiber, David, |
Relator term |
author. |
9 (RLIN) |
118468 |
245 10 - TITLE STATEMENT |
Title |
Anticancer : |
Remainder of title |
a new way of life / |
Statement of responsibility, etc |
David Servan-Schreiber, MD, PhD. |
246 3# - VARYING FORM OF TITLE |
Title proper/short title |
Anti-cancer |
250 ## - EDITION STATEMENT |
Edition statement |
[Second edition] |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE STATEMENTS |
Place of production, publication, distribution, manufacture |
New York : |
Name of producer, publisher, distributor, manufacturer |
Penguin Books, |
Date of production, publication, distribution, manufacture |
2017. |
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE STATEMENTS |
Date of production, publication, distribution, manufacture |
©2009 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
274 pages, [16] pages of plates : |
Other physical details |
illustrations (some color) ; |
Dimensions |
22 cm |
336 ## - CONTENT TYPE |
Content Type Term |
text |
Content Type Code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media Type Term |
unmediated |
Media Type Code |
n |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier Type Term |
volume |
Carrier Type Code |
nc |
Source |
rdacarrier |
500 ## - GENERAL NOTE |
General note |
"Originally published in French by Éditions Robert Laffont, S.A. Paris, 2007." |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references (pages 229-260) and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
One story -- Escaping statistics -- Danger and opportunity -- Cancer's weaknesses -- Breaking the news -- The anticancer environment -- Lessons of a relapse -- The anticancer foods -- The anticancer mind -- Defusing fear -- The anticancer body -- Learning to change -- Conclusion. |
520 ## - SUMMARY, ETC. |
Summary, etc |
This new edition addresses current developments in cancer research and offers more tips on how people living with cancer can fight it and how healthy people can prevent it. The new edition includes: the latest research on anticancer foods, including new alternatives to sugar and cautions about some that are now on the market; new information about how vitamin D strengthens the immune system; warnings about common food contaminants that have recently been proven to contribute to cancer progression; a new chapter on mind-body approaches to stress reduction, with recent studies that show how our reactions to stress can interfere with natural defenses and how friendships can support healing in ways never before understood; a groundbreaking study showing that lifestyle modification reduces mortality for breast cancer by an astounding 68 percent after completion of treatment; and new supporting evidence for the entire Anticancer program.--From publisher description. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Cancer |
General subdivision |
Prevention. |
9 (RLIN) |
98904 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Cancer |
General subdivision |
Adjuvant treatment. |
9 (RLIN) |
118469 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Cancer |
General subdivision |
Alternative treatment. |
9 (RLIN) |
101602 |
994 ## - |
-- |
C0 |
-- |
NFG |